
LL-37
$65.00
LL-37, the human cathelicidin antimicrobial peptide studied in innate immunity and anti-biofilm research.
- Purity
- >99%
- Testing
- 3rd-party
- Shipping
- Tracked, discreet
Need the Certificate of Analysis for this batch? Request a COA.
About LL-37
LL-37 (Cathelicidin Antimicrobial Peptide)
Innate immunity's front line. Antimicrobial and immunomodulatory research.
LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminal domain of the precursor protein hCAP-18. Expressed by neutrophils, epithelial cells, and macrophages, LL-37 serves as a critical component of the innate immune system. Beyond its direct antimicrobial activity, LL-37 has been studied for its immunomodulatory, wound healing, and anti-biofilm properties, making it a multifaceted research compound of significant interest.
Research applications
- Broad-spectrum antimicrobial activity and membrane disruption mechanisms
- Innate immune system modulation and toll-like receptor interaction
- Wound healing, angiogenesis, and tissue repair pathway research
- Anti-biofilm activity and bacterial membrane permeabilization studies
- Immunomodulatory cytokine regulation and inflammation research



